LYON, France--(BUSINESS WIRE)--POXEL SA (Euronext: POXEL), a biopharmaceutical company developing innovative drugs to treat type 2 diabetes, announced today that Noah D. Beerman has joined the company as Executive Vice President, Business Development and President, US Operations to spearhead Poxel’s expanding presence into the USA. Mr. Beerman will be based in the Boston area, and is responsible for leading Poxel’s global business development efforts, and for continuing to build the Company’s relationships with the US financial community.
Help employers find you! Check out all the jobs and post your resume.
